China SXT Pharmaceuticals Inc. (SXTC)
SXTC trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.0774
-24.12% on the day
Market cap
$802K
Nano cap
Revenue · 2025
$1.1M
Prior year not contiguous
Net income · 2025
-$6.2M
-545.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1723980/000121390026074310/0001213900-26-074310-index.htm. Net income: SEC 20-F (us-gaap:NetIncomeLoss), period ending 2026-03-31.
Profile
| Field | Value |
|---|---|
| Ticker | SXTC on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | China |
| IPO year | 2019 |
| SEC CIK | 0001723980 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | D8 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.1M |
| Net income | -$6.2M |
| Operating income | -$7.1M |
| Net margin | -545.2% |
| Operating margin | -625.9% |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.7× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2026-10-09 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-07-01 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-10-09 |
Source: SEC EDGAR submissions feed, 167 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CDT | CDT Equity Inc. | $0.4500 | -31.82% | $506K |
| BDRX | Biodexa Pharmaceuticals plc American Depositary Shs | $0.3502 | -8.61% | $1.5M |
| ARTL | Artelo Biosciences Inc. | $2.98 | -4.18% | $1.6M |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | $0.6939 | -5.08% | $1.6M |
| OGEN | Oragenics Inc. | $0.4469 | -0.16% | $2.0M |
| GNPX | Genprex Inc. | $2.51 | -6.69% | $2.1M |
| SILO | Silo Pharma Inc. | $1.22 | -18.12% | $2.1M |
| PPBT | Purple Biotech Ltd. | $1.36 | -1.45% | $2.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier